Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick S Barrett

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|October 6, 2025
Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related CompoundsMegan M Hosein, Matthew J Reid, Sarah Walser, et al.
Journal of Substance Abuse Treatment|September 28, 2016
Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban SettingKelly E Dunn, Frederick S Barrett, Claudia Yepez-Laubach, et al.
The Lancet. Psychiatry|August 25, 2023
Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studiesGustavo C Medeiros, Malcolm Matheson, Isabella Demo, et al.
Pain|February 13, 2019
Pain-related nucleus accumbens function: modulation by reward and sleep disruptionDavid A Seminowicz, Bethany Remeniuk, Samuel R Krimmel, et al.
Translational Psychiatry|November 9, 2021
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorderManoj K Doss, Michal Považan, Monica D Rosenberg, et al.
Schizophrenia Bulletin|October 6, 2025
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesNathan H Heller, Frederick S Barrett, Tobias Buchborn, et al.
Journal of Psychopharmacology (Oxford, England)|February 5, 2026
Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compoundsBenjamin R Lewis, Matthew J Reid, Andrew M Novick, et al.
The American Journal of Psychiatry|January 1, 2024
Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted TherapyKelley C O'Donnell, Brian T Anderson, Frederick S Barrett, et al.
Neurobiology of Disease|May 18, 2017
Molecular imaging of serotonin degeneration in mild cognitive impairmentGwenn S Smith, Frederick S Barrett, Jin Hui Joo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 17, 2016
LSD modulates music-induced imagery via changes in parahippocampal connectivityMendel Kaelen, Leor Roseman, Joshua Kahan, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|October 6, 2025
Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related CompoundsMegan M Hosein, Matthew J Reid, Sarah Walser, et al.
Journal of Substance Abuse Treatment|September 28, 2016
Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban SettingKelly E Dunn, Frederick S Barrett, Claudia Yepez-Laubach, et al.
The Lancet. Psychiatry|August 25, 2023
Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studiesGustavo C Medeiros, Malcolm Matheson, Isabella Demo, et al.
Pain|February 13, 2019
Pain-related nucleus accumbens function: modulation by reward and sleep disruptionDavid A Seminowicz, Bethany Remeniuk, Samuel R Krimmel, et al.
Translational Psychiatry|November 9, 2021
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorderManoj K Doss, Michal Považan, Monica D Rosenberg, et al.
Schizophrenia Bulletin|October 6, 2025
Visual Hallucinations in Serotonergic Psychedelics and Lewy Body DiseasesNathan H Heller, Frederick S Barrett, Tobias Buchborn, et al.
Journal of Psychopharmacology (Oxford, England)|February 5, 2026
Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers' task group on psychedelics and related compoundsBenjamin R Lewis, Matthew J Reid, Andrew M Novick, et al.
The American Journal of Psychiatry|January 1, 2024
Misinterpretations and Omissions: A Critical Response to Goodwin and Colleagues' Commentary on Psilocybin-Assisted TherapyKelley C O'Donnell, Brian T Anderson, Frederick S Barrett, et al.
Neurobiology of Disease|May 18, 2017
Molecular imaging of serotonin degeneration in mild cognitive impairmentGwenn S Smith, Frederick S Barrett, Jin Hui Joo, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 17, 2016
LSD modulates music-induced imagery via changes in parahippocampal connectivityMendel Kaelen, Leor Roseman, Joshua Kahan, et al.
Pageof 8